文献速递中毒与环境急症消化、代谢与肾脏急症

阿片类药物使用障碍患者住院或急诊就诊后启动药物治疗与阿片过量 overdose 的关联

Opioid Overdose After Medication for Opioid Use Disorder Initiation Following Hospitalization or ED Visit.
PubMed 文献 · JAMA Netw Open · 2024-07-01
一句话结论OUD相关住院或急诊就诊后7天内启动MOUD与6个月阿片过量odds降低相关(AOR 0.63),12个月无差异,作者建议医院考虑实施启动MOUD的项目。

这项基于俄勒冈综合阿片风险登记处的队列研究纳入22235例2017年1月至2019年12月因OUD相关诊断在急诊或住院就诊的成人,评估就诊后7天内启动MOUD与6、12个月致命或非致命阿片过量的关联。1184例(5.3%)在7天内接受MOUD,其中683例(57.7%)用丁丙诺啡、463例(39.1%)用美沙酮、46例(3.9%)用长效注射纳曲酮。接受MOUD者6个月过量调整OR为0.63(95%CI 0.41-0.97),12个月为0.79(95%CI 0.58-1.08)。丁丙诺啡使用与6个月过量风险降低相关(AOR 0.50;95%CI 0.27-0.95),美沙酮无此关联(AOR 0.57;95%CI 0.28-1.17)。作者认为医院应考虑实施为OUD就诊患者提供MOUD启动的项目和流程。

要点

  • OUD相关住院或急诊就诊后7天内启动MOUD者6个月致命或非致命过量调整OR为0.63(95%CI 0.41-0.97),低于未启动者。
  • 12个月时两组过量调整OR为0.79(95%CI 0.58-1.08),未达统计学显著差异。
  • 丁丙诺啡使用与6个月过量风险降低相关(AOR 0.50;95%CI 0.27-0.95),美沙酮使用无此关联(AOR 0.57;95%CI 0.28-1.17)。
  • 全部22235例中仅1184例(5.3%)在就诊后7天内启动MOUD,其中丁丙诺啡683例(57.7%)、美沙酮463例(39.1%)、长效注射纳曲酮46例(3.9%)。
  • 作者认为医院应考虑实施项目和流程,为就诊的OUD患者提供MOUD启动。

适用人群与场景

  • 2017年1月至2019年12月期间在急诊就诊或住院时记录有OUD相关诊断代码的18岁及以上个体,数据来自俄勒冈综合阿片风险登记处。
  • 研究人群53.1%为女性,25.0%年龄在25-39岁。

处置流程与药物剂量

  • 暴露定义为OUD相关住院就诊后7天内接受MOUD。
  • 接受MOUD的1184例中,683例(57.7%)接受丁丙诺啡,463例(39.1%)接受美沙酮,46例(3.9%)接受长效注射纳曲酮。
  • 作者认为医院应考虑实施项目和流程,为因OUD就诊的患者提供MOUD启动。

研究设计与关键结果

  • 研究类型为基于人群的队列研究,纳入22235例OUD相关急诊或住院就诊患者,主要终点为出院后6个月和12个月致命或非致命过量。
  • 接受MOUD者6个月致命或非致命过量调整OR为0.63(95%CI 0.41-0.97),低于未接受者。
  • 12个月时两组过量调整OR为0.79(95%CI 0.58-1.08),无差异。
  • 丁丙诺啡使用与6个月过量风险降低相关(AOR 0.50;95%CI 0.27-0.95),美沙酮使用无此关联(AOR 0.57;95%CI 0.28-1.17)。

证据类型、等级与局限

  • 证据类型:基于人群的队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为医院应考虑实施项目和流程,为因OUD就诊的患者提供MOUD启动。
  • 本研究显示就诊后7天内启动MOUD与6个月阿片过量odds降低相关,12个月时无差异;丁丙诺啡使用与6个月过量风险降低相关,美沙酮使用无此关联。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Hospitalizations related to opioid use disorder (OUD) represent an opportunity to initiate medication for OUD (MOUD).

OBJECTIVE: To assess whether starting MOUD after a hospitalization or emergency department (ED) visit is associated with the odds of fatal and nonfatal opioid overdose at 6 and 12 months.

DESIGN, SETTING, AND PARTICIPANTS: This population-based cohort study used data from the Oregon Comprehensive Opioid Risk Registry, which links all payer claims data to other administrative health datasets, for individuals aged 18 years or older who had diagnosis codes related to OUD recorded at an index ED visit or hospitalization from January 2017 to December 2019. Data were analyzed between May 2023 and January 2024.

EXPOSURES: Receipt of MOUD within the 7 days after an OUD-related hospital visit.

MAIN OUTCOMES AND MEASURES: The primary outcome was fatal or nonfatal overdose at 6 and 12 months after discharge. Sample characteristics, including age, sex, insurance plan, number of comorbidities, and opioid-related overdose events, were stratified by receipt or nonreceipt of MOUD within 7 days after an OUD-related hospital visit. A logistic regression model was used to investigate the association between receipt of MOUD and having an opioid overdose event.

RESULTS: The study included 22 235 patients (53.1% female; 25.0% aged 25-39 years) who had an OUD-related hospital visit during the study period. Overall, 1184 patients (5.3%) received MOUD within 7 days of their ED visit or hospitalization. Of these patients, 683 (57.7%) received buprenorphine, 463 (39.1%) received methadone, and 46 (3.9%) received long-acting injectable naltrexone. Patients who received MOUD within 7 days after discharge had lower adjusted odds of fatal or nonfatal overdose at 6 months compared with those who did not (adjusted odds ratio [AOR], 0.63; 95% CI, 0.41-0.97). At 12 months, there was no difference in adjusted odds of fatal or nonfatal overdose between these groups (AOR, 0.79; 95% CI, 0.58-1.08). Patients had a lower risk of fatal or nonfatal overdose at 6 months associated with buprenorphine use (AOR, 0.50; 95% CI, 0.27-0.95) but not with methadone use (AOR, 0.57; 95% CI, 0.28-1.17).

CONCLUSIONS AND RELEVANCE: In this cohort study of individuals with an OUD-related hospital visit, initiation of MOUD was associated with reduced odds of opioid-related overdose at 6 months. Hospitals should consider implementing programs and protocols to offer initiation of MOUD to patients with OUD who present for care.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Weiner SG, Little K, Yoo J, et al. Opioid Overdose After Medication for Opioid Use Disorder Initiation Following Hospitalization or ED Visit. JAMA Netw Open. 2024. PMID: 39037812. doi:10.1001/jamanetworkopen.2024.23954

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。